San Diego, CA, United States of America

Joseph L Witztum

This inventor holds 34 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Cardiovascular Diagnostics. Top assignees: University of California, Scripps Research Institute, National Institute of Health and Medical Research. Active years: 1988-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph L Witztum. Retrieved from https://idiyas.com/inventor/joseph-l-witztum

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34 

% Patents Active = 85.3

 

 

Average Co-Inventor Count = 3.1

ph-index = 8

Forward Citations = 256(Granted Patents)


Location History:

  • Sand Diego, CA (US) (2009)
  • La Jolla, CA (US) (2013)
  • San Diego, CA (US) (1988 - 2024)

Company Filing History:


Years Active: 1988-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Cardiovascular Disease
Oxidized Phospholipids
Antibodies
Atherogenesis
Ischemic Injury
TLR2-Mediated Disorders
Stroke Prediction
Apolipoprotein B
Glycosylated Hemoglobin
Immunochemical Methods
Atherosclerotic Imaging
34 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Joseph L Witztum in Medical Science**

Introduction

Joseph L Witztum, based in San Diego, CA, has made significant strides in the field of medical research, particularly focusing on the treatment of various diseases through innovative approaches. With an impressive portfolio of 30 patents, his contributions have paved the way for novel therapeutic strategies.

Latest Patents

Witztum's latest patents showcase his cutting-edge research in medical treatments. One notable patent is the "Method of treating rheumatoid arthritis using antibodies to oxidized phospholipids." This invention encompasses single chain variable fragments that target oxidized phospholipid epitopes, offering potential as therapeutic agents for treating cardiovascular diseases. Another significant patent is the "Inhibition of oxidation-specific epitopes to treat ischemic reperfusion injury," which outlines methods for treating ischemic injury, stroke, and myocardial infarctions by administering antibodies or antibody fragments swiftly to inhibit the harmful biological activity of oxidized phospholipids in affected tissues.

Career Highlights

Throughout his career, Joseph L Witztum has held pivotal roles at respected research institutions, including the University of California and The Scripps Research Institute. His work not only emphasizes his expertise in medical innovations but also highlights his commitment to advancing therapeutic methodologies aimed at improving patient health outcomes.

Collaborations

Witztum has collaborated with esteemed colleagues such as Sotirios Tsimikas and Linda K Curtiss, with whom he has shared insights and expertise in the field of research. These collaborations have enriched his research endeavors and contributed to the development of innovative solutions for complex medical conditions.

Conclusion

Joseph L Witztum's dedication to research and his impressive patent contributions illustrate the pivotal role innovators play in advancing medical science. His work continues to inspire future generations of inventors and researchers dedicated to finding novel treatments for serious health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…